Skip to main content

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Verónica Villagrasa Araya

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

The project aims to improve prevention, diagnosis, and treatment through computational biomedicine, innovative therapies, and the transfer of knowledge into clinical practice.

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Related professionals

Rafael Garcia Merida

Rafael Garcia Merida

Administration and Management
Clinical Neuroimmunology
Read more
Arnau Hervera Abad

Arnau Hervera Abad

Main researcher
Clinical Neuroimmunology
Read more
Cristina de Dios Conde

Cristina de Dios Conde

Tècnic/a Superior Recerca
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more
Shirley Guzmán Avilés

Shirley Guzmán Avilés

Tècnic/a Grau Superior
External Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.